Drug Maintenance Dose Rate: Clinical Guide

Overview

Calculates a theoretical maintenance dose rate from target steady-state concentration, clearance and bioavailability.

Clinical Significance

The result is a theoretical average input rate at steady state. Clinical regimens must reflect the drug’s dosing interval, therapeutic index, organ function and approved protocol.

When to Use

• Use when a drug-specific pharmacokinetic model permits concentration-targeted dosing.
• Use an appropriate estimate of drug clearance.
• Convert the hourly rate into a regimen only after protocol and formulation checks.

How It Is Calculated

• Maintenance dose rate = target steady-state concentration × clearance ÷ bioavailability.
• The calculator validates the required inputs before applying the equation and rounds only the displayed result.

Interpretation

• The result is a theoretical average input rate at steady state. Clinical regimens must reflect the drug's dosing interval, therapeutic index, organ function and approved protocol.
• Review the component values and assumptions as well as the final result.

Worked Example

Enter clinically plausible values in the stated units. MedicalC applies: Maintenance dose rate = target steady-state concentration × clearance ÷ bioavailability. Review the displayed result against the source data and the relevant clinical pathway.

Patient Considerations

• Confirm that the patient and clinical setting match the population or physiologic assumptions behind the equation.
• Consider whether treatment, organ function, pregnancy, body composition, sampling conditions or acute illness materially alter interpretation.
• Use serial calculations only when methods and units remain comparable.

Limitations

• Clearance can change rapidly with organ function and critical illness.
• The relationship assumes linear, time-invariant pharmacokinetics.
• It does not determine loading dose or time to steady state.

Clinical Pearls

• For continuous intravenous infusion, bioavailability is 1.
• Recalculate when clearance changes materially.
• Use therapeutic drug monitoring for narrow-therapeutic-index medicines.

Common Mistakes

• Confusing drug clearance with creatinine clearance.
• Using a target concentration in incompatible units.
• Converting the rate to a dose interval without checking maximum dose and administration constraints.

Evidence Base

The implementation uses the published or established relationship: Maintenance dose rate = target steady-state concentration × clearance ÷ bioavailability. The cited source should be reviewed alongside current specialty guidance before clinical deployment.

References

1. Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. — Primary publication, authoritative guideline or recognised clinical source supporting the calculation.